About 19% of patients with asthma received a combination of DPI and pMDI inhalers vs 35% of those with COPD. A significant proportion of elderly patients (aged ≥75 years) received mixed devices ...

Innovata Biomed Ltd has developed an alternative device, the Clickhaler®, which is a multiple-dose dry powder inhaler (DPI). The present ... Adult patients with asthma who were receiving ...

If, for example, a patient with asthma needs to step up their regular preventor ... to identify patients on MDI inhalers for whom a DPI is clinically appropriate, switch them, explain why they have ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...

Though prescribing climate-friendly inhalers is environmentally sound, some experts warn certain patients may be overlooked.

and dry powder inhaler (DPI) devices. DPI device availability is limited to "controller" medications, while pMDI devices and nebulizers provide complete symptomatic coverage. Multiple-dose DPIs ...

1 There is a national 2,3 and local 4,5 drive to reduce the use of MDI’s in favour of dry-powder inhalers (DPI’s) which are better for the planet. Within our cohort of children with severe asthma we ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA ...

Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive pulmonary disorder (COPD) in their portfolios, have each committed to becoming ...